Fudging these details could lead to wonky dosing and maybe some not-great stuff for your health
Coverage requires provider approval, prior authorization, and CMS eligibility rules
The only study was conducted on rats and explicitly states it cannot guide human dosing
If a provider determines that treatment is appropriate, they can prescribe medication that ships directly to the patient
According to Cullaro et al., in their complete review of national registry data, there was a 187% increase in the proportion of patients with cirrhosis and CKD at the time of liver transplant between 2002 and 2017. Furthermore, they reported, CKD at transplant was associated with a 16% independent higher risk of mortality post-liver transplant after adjusting for factors such as recipient age, etiology of cirrhosis, ethnicity, hepatic encephalopathy, era of transplant, diabetes mellitus, and donor risk index. This demonstrates the rising prevalence of CKD and its detrimental effects on patients undergoing liver transplantation
